Magnolia champaca

Magnolia champaca

Product Name: Магнолия длиннолепестная, Magnolia champaca, Champaka-Magnolie, Champaca, magnolia champaca, ميشيل الماغنوليا, จำปา, чампака, чампака, чампака, шампак, шампак, magnolija champaka, magnolija čampaka, магнолія чампака, чампака, מגנוליה צ'מפאקה

Synonyms: магнолия шампака, магнолия жёлтая, магнолия душистая, Champak, Joy perfume tree, Yellow champak, Michelia champaca, Champaka-Magnolie, Gold-Champaca, Champaca amarillo, Champaca, Michelia jaune, ميشيل الشمباكا, ไม้จำปา

Parts Used: flowers, essential oil from flowers, leaves, bark, seeds, fruits

Main Indications for the Use of Magnolia champaca: chronic bronchitis, bronchial asthma, chronic rhinitis, sinusitis, periodontitis, oral candidiasis, chronic gastritis, functional dyspepsia, peptic ulcer of the stomach, pyelonephritis, cystitis, dysmenorrhea, algodismenorrhea, leukorrhea, neurasthenia, insomnia, depressive disorder, arterial hypertension, atherosclerosis, ischemic heart disease, tachycardia, dermatomycosis, pyoderma, eczema, psoriasis.

Use of Magnolia champaca in Mixtures and Complexes: chronic obstructive pulmonary disease, acute sinusitis, acute bronchitis, acute gastritis, acute cystitis, endometriosis, climacteric syndrome, type 2 diabetes mellitus, obesity, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, seborrheic dermatitis.

Pharmacological Properties of Magnolia champaca: anti-inflammatory, antimicrobial, antifungal, spasmolytic, expectorant, sedative, hypotensive, antidepressant, antioxidant, vasodilatory, hepatoprotective, wound-healing, astringent, insecticidal.

Dosage of Pharmaceutical Forms — Magnolia champaca

Powder — Magnolia champaca

Indications (Powder): chronic bronchitis, chronic rhinitis, oral candidiasis, chronic gastritis, peptic ulcer of the stomach, pyelonephritis, cystitis, algodismenorrhea, leukorrhea, insomnia, arterial hypertension, atherosclerosis, dermatomycosis, eczema, psoriasis.

Standard Dosage (Powder): 1–2 grams of powder 2 times a day, with warm water, 30 minutes before meals.

Enhanced Dosage (Powder): 2 grams of powder 3 times a day for chronic bronchitis, oral candidiasis, peptic ulcer of the stomach, algodismenorrhea.

Maximum Dosage (Powder): 3 grams of powder 3 times a day for severe chronic gastritis, pronounced pyelonephritis, arterial hypertension — course no more than 10 days.

Preventive Dosage (Powder): 1 gram of powder once a day, in the morning, 30 minutes before breakfast, in courses of 20 days every 2 months, for chronic rhinitis, atherosclerosis, insomnia, for patients over 40 years of age.

Pediatric Dosage (Powder): for children over 12 years of age and weighing more than 40 kg — 0.5 grams of powder once a day; for children under 12 years of age, data on use are not scientifically registered.

Contraindications (Powder): individual intolerance, acute gastritis, acute nephritis; data on contraindications during pregnancy, lactation, and in children under 12 years of age are not scientifically registered.

Side Effects (Powder): nausea, heartburn; in case of overdose — diarrhea, abdominal pain.

Adjustment for Patient Body Weight (Powder): for body weight below 60 kg — dosage reduction by 25%; for body weight above 90 kg — dosage increase by 20%.

Preparation Method (Powder): Dried petals of Magnolia champaca are used. To prepare 100 g of product: petals — 100 g. Grind the raw material in a mill to a powdery state, sift through a sieve with a mesh size of 0.5 mm. Store in an airtight container.

Storage Conditions and Shelf Life (Powder): store in a dry, dark place, at a temperature from +5 to +20 °C, in an airtight package, away from sources of electromagnetic radiation; shelf life — 24 months; after opening — 6 months.

Dry Extract — Magnolia champaca

Indications (Dry Extract): chronic bronchitis, chronic rhinitis, oral candidiasis, chronic gastritis, peptic ulcer of the stomach, pyelonephritis, cystitis, algodismenorrhea, insomnia, arterial hypertension, atherosclerosis, dermatomycosis, eczema, psoriasis.

Standard Dosage (Dry Extract): 300 mg of dry extract 2 times a day, orally, 30 minutes before meals.

Enhanced Dosage (Dry Extract): 500 mg of dry extract 2 times a day for chronic bronchitis, oral candidiasis, algodismenorrhea, insomnia.

Maximum Dosage (Dry Extract): 600 mg of dry extract 3 times a day for pronounced arterial hypertension, severe chronic gastritis, exacerbation of atherosclerosis — course up to 7 days.

Preventive Dosage (Dry Extract): 150 mg of dry extract once a day in the morning, course 20 days every 3 months, for patients with chronic rhinitis, insomnia, mild atherosclerosis.

Pediatric Dosage (Dry Extract): for children over 14 years of age and weighing more than 50 kg — 100 mg once a day; for children under 14 years of age, data on use are not scientifically registered.

Contraindications (Dry Extract): individual intolerance, acute nephritis, severe forms of liver failure; data on contraindications during pregnancy, lactation, and in children under 14 years of age are not scientifically registered.

Side Effects (Dry Extract): in case of overdose — headache, nausea, hypotension.

Adjustment for Patient Body Weight (Dry Extract): for weight below 60 kg — dosage reduction by 20%; for weight above 90 kg — increase by 15%.

Preparation Method (Dry Extract): To prepare 100 g of extract: dry petals of Magnolia champaca — 500 g, 70% ethanol — 1500 ml (used only for extraction and is not a component of the finished preparation). The raw material is infused in ethanol at a temperature of 25 °C for 72 hours, filtered, the extractant is evaporated in a water bath at a temperature not exceeding 50 °C until the ethanol odor completely disappears (residual content ≤ 50 ppm). The resulting concentrate is dried in a vacuum drying cabinet at 40 °C to a powdery state.

Storage Conditions and Shelf Life (Dry Extract): store in an airtight container, in a dark, dry place at a temperature from +5 to +20 °C, away from direct sunlight and sources of electromagnetic radiation; shelf life — 24 months; after opening — 6 months.

Oil Infusion — Magnolia champaca

Indications (Oil Infusion): chronic bronchitis, chronic rhinitis, oral candidiasis, pyelonephritis, cystitis, algodismenorrhea, insomnia, arterial hypertension, dermatomycosis, eczema, psoriasis.

Standard Dosage (Oil Infusion): external use — apply 1–2 ml to the affected area of the skin 2 times a day; internal use — 2 ml 2 times a day, 30 minutes before meals.

Enhanced Dosage (Oil Infusion): external use — 3 ml 3 times a day for pronounced inflammatory dermatoses; internal use — 3 ml 2 times a day for chronic bronchitis, insomnia.

Maximum Dosage (Oil Infusion): external use — up to 5 ml per skin area up to 200 cm²; internal use — 5 ml 2 times a day for severe chronic rhinitis, algodismenorrhea, course no more than 7 days.

Preventive Dosage (Oil Infusion): 1 ml externally or 1 ml internally once a day, in courses of 14 days every 2 months, for chronic rhinitis, insomnia, mild arterial hypertension.

Pediatric Dosage (Oil Infusion): external use — for children over 6 years of age and weighing more than 20 kg — 0.5 ml once a day; internal use — data on safety are not scientifically registered.

Contraindications (Oil Infusion): individual intolerance, allergic reactions to essential oils; data on contraindications during pregnancy, lactation, and internal use in children under 14 years of age are not scientifically registered.

Side Effects (Oil Infusion): in case of overdose — skin irritation, headache, nausea.

Adjustment for Patient Body Weight (Oil Infusion): for weight below 60 kg — dosage reduction by 20%; for weight above 90 kg — increase by 15%.

Preparation Method (Oil Infusion): To prepare 100 g of infusion: fresh petals of Magnolia champaca — 20 g, unrefined coconut oil — 80 g. Grind the petals, place in a glass jar, pour with oil, heat in a water bath at a temperature of 40 °C for 6 hours, stirring periodically. Infuse for 48 hours at a temperature of 25 °C, then filter through cheesecloth.

Storage Conditions and Shelf Life (Oil Infusion): store in an airtight dark glass container, at a temperature from +5 to +20 °C, away from sunlight and heat sources; shelf life — 12 months; after opening — 3 months.

Absolute — Magnolia champaca

Indications (Absolute): chronic bronchitis, chronic rhinitis, oral candidiasis, insomnia, arterial hypertension, dermatomycosis, eczema, psoriasis.

Standard Dosage (Absolute): external use — 1–2 drops, diluted in 5 ml of carrier oil, apply to the affected area 1–2 times a day; aromatherapy — 1 drop per 100 ml of water in an aroma lamp, 20–30 minutes.

Enhanced Dosage (Absolute): external use — 3 drops in 5 ml of carrier oil 2 times a day for pronounced dermatomycosis, eczema; aromatherapy — 2 drops per 100 ml of water for insomnia, chronic bronchitis.

Maximum Dosage (Absolute): external use — 5 drops in 5 ml of carrier oil, course no more than 10 days; aromatherapy — 3 drops per 100 ml of water, no more than 30 minutes per day.

Preventive Dosage (Absolute): external use — 1 drop in 5 ml of carrier oil once a day, course 14 days every 3 months, for chronic rhinitis, mild arterial hypertension.

Pediatric Dosage (Absolute): for children over 12 years of age — 1 drop in 10 ml of carrier oil, externally; data on internal use and use in children under 12 years of age are not scientifically registered.

Contraindications (Absolute): individual intolerance, allergy to essential oils; data on contraindications during pregnancy, lactation, and in children under 12 years of age are not scientifically registered.

Side Effects (Absolute): in case of overdose — skin irritation, headache, nausea.

Adjustment for Patient Body Weight (Absolute): for weight below 60 kg — dosage reduction by 25%; for weight above 90 kg — increase by 20%.

Preparation Method (Absolute): To prepare 100 g of absolute: fresh petals of Magnolia champaca — 5 kg, hexane — 2 L (used only for extraction and is not a component of the finished preparation). Place the petals in an extractor, pour with hexane, hold at 20 °C for 8 hours. The resulting concrete is filtered, then the solvent is evaporated in a water bath at a temperature not exceeding 50 °C until the odor completely disappears (residual content ≤ 10 ppm). The concrete is washed with 96% ethanol, then the solvent is removed again.

Storage Conditions and Shelf Life (Absolute): store in an airtight dark glass container, at a temperature from +5 to +15 °C, away from light and heat sources; shelf life — 24 months; after opening — 6 months.

Essential Oil — Magnolia champaca

Indications (Essential Oil): chronic bronchitis, chronic rhinitis, oral candidiasis, insomnia, arterial hypertension, dermatomycosis, eczema, psoriasis.

Standard Dosage (Essential Oil): external use — 2–3 drops, diluted in 10 ml of coconut oil, apply to the affected area of the skin 1–2 times a day; aromatherapy — 1–2 drops per 100 ml of water in an aroma lamp, 20–30 minutes.

Enhanced Dosage (Essential Oil): external use — 4 drops in 10 ml of coconut oil 2 times a day for pronounced dermatomycosis or eczema; aromatherapy — 3 drops per 100 ml of water for insomnia, chronic bronchitis.

Maximum Dosage (Essential Oil): external use — 5 drops in 10 ml of coconut oil, course no more than 14 days; aromatherapy — 4 drops per 100 ml of water, no more than 40 minutes per day.

Preventive Dosage (Essential Oil): external use — 1 drop in 10 ml of coconut oil once a day, course 14 days every 3 months, for chronic rhinitis, mild arterial hypertension, for patients over 40 years of age.

Pediatric Dosage (Essential Oil): for children over 12 years of age — 1 drop in 15 ml of coconut oil, externally; data on internal use and in children under 12 years of age are not scientifically registered.

Contraindications (Essential Oil): individual intolerance, allergy to essential oils; data on contraindications during pregnancy, lactation, and in children under 12 years of age are not scientifically registered.

Side Effects (Essential Oil): in case of overdose — skin irritation, headache, nausea, lowering of blood pressure.

Adjustment for Patient Body Weight (Essential Oil): for weight below 60 kg — dosage reduction by 25%; for weight above 90 kg — increase by 15%.

Preparation Method (Essential Oil): To prepare 100 g of essential oil: fresh petals of Magnolia champaca — 10 kg, distilled water — 15 L. The raw material is placed in a distillation still, steam distillation is carried out at a temperature of 98–100 °C for 6–8 hours. The oil is separated from the hydrolate using a separating funnel.

Storage Conditions and Shelf Life (Essential Oil): store in an airtight dark glass container, at a temperature from +5 to +15 °C, away from light and heat sources; shelf life — 24 months; after opening — 6 months.

Face Wash — Magnolia champaca

Indications (Face Wash): dermatomycosis, eczema, psoriasis, seborrheic dermatitis, acne, rosacea.

Standard Dosage (Face Wash): use 2 times a day (morning and evening), 2 ml of product per wash, rinse thoroughly with warm water.

Enhanced Dosage (Face Wash): use 3 times a day for pronounced acne, seborrheic dermatitis, or rosacea.

Maximum Dosage (Face Wash): up to 4 times a day for no more than 7 days for pronounced inflammatory lesions of the facial skin.

Preventive Dosage (Face Wash): once a day, in the evening, in courses of 30 days every 3 months, for patients with chronic seborrheic dermatitis, rosacea, tendency to acne.

Pediatric Dosage (Face Wash): for children over 10 years of age — 1 ml of product once a day; data on use in children under 10 years of age are not scientifically registered.

Contraindications (Face Wash): individual intolerance, acute purulent skin lesions; data on contraindications during pregnancy, lactation, and in children under 10 years of age are not scientifically registered.

Side Effects (Face Wash): in case of overdose — dry skin, irritation, itching.

Adjustment for Patient Body Weight (Face Wash): not required.

Preparation Method (Face Wash): To prepare 100 g of product: coconut oil — 15 g, distilled water — 75 g, mild plant-derived surfactant (coco-glucoside) — 7 g, Magnolia champaca hydrolate — 2 g, Magnolia champaca essential oil — 0.5 g, plant-derived preservative (e.g., rosemary extract) — 0.5 g. Mix the oil with the surfactant, add water and hydrolate at a temperature of 30–35 °C, mix thoroughly, add the essential oil and preservative, mix until homogeneous.

Storage Conditions and Shelf Life (Face Wash): store in an airtight bottle, in a dark place, at a temperature from +5 to +20 °C, away from heat sources; shelf life — 12 months; after opening — 3 months.

Toxicity and Biosafety of Magnolia champaca

Toxicity studies of Magnolia champaca have shown that plant extracts have low acute toxicity. In experimental models on laboratory rodents, oral administration of methanolic extract of Magnolia champaca at doses up to 2000 mg/kg body weight did not cause death or pronounced clinical signs of intoxication, indicating an LD₅₀ > 2000 mg/kg. Long-term use of extracts in therapeutic doses did not demonstrate significant changes in biochemical and morphological parameters of the liver, kidneys, and heart. Data on chronic toxicity and mutagenicity in humans are absent, but isolated cases of contact dermatitis have been reported with external use in the form of essential oils and infusions.

Reference: https://doi.org/10.1016/j.jep....

Pharmacodynamics — Magnolia champaca

Magnolia champaca is characterized by a multifaceted pharmacodynamic profile due to a complex of biologically active compounds, including mono- and sesquiterpenoids, phenolic compounds, flavonoids, alkaloids, and essential oils. These substances exhibit a wide range of biological effects at the systemic and local levels. Studies demonstrate a pronounced anti-inflammatory effect associated with the modulation of the synthesis of pro-inflammatory mediators, such as prostaglandins and cytokines, through inhibition of cyclooxygenase and lipoxygenase activity. Antimicrobial activity is realized through the disruption of the integrity of microbial cell membranes and the suppression of bacterial and fungal enzyme systems.

The sedative and anxiolytic effect of Magnolia champaca is associated with an influence on the central nervous system, in particular with the modulation of the activity of GABAergic and serotonergic neurotransmitter pathways. Components of the essential oil have a mild muscle relaxant effect, and can also affect autonomic regulation, reducing the level of sympathetic activity. Antioxidant activity has been noted, due to the presence of phenolic compounds that effectively neutralize free radicals, reducing oxidative stress at the cellular level.

The effect on the cardiovascular system includes a vasodilating effect and improved microcirculation, which is associated with modulation of vascular wall tone through influence on endothelial mediators. At the level of the respiratory system, essential components and terpenoids exhibit bronchodilatory activity, promoting relaxation of bronchial smooth muscles. Local application of Magnolia champaca extracts and oils to the skin exhibits regenerative and antiseptic potential, improves epithelialization, and reduces bacterial colonization.

The effect on the immune system is associated with a moderate immunomodulatory effect, expressed in the normalization of the production of certain cytokines and an increase in the activity of phagocytic cells. A possible influence on the endocrine system through interaction with receptor structures involved in the regulation of the stress response has been noted. The totality of pharmacodynamic properties of Magnolia champaca allows it to be considered as a source of multidirectional biologically active substances acting through various physiological mechanisms.

References: https://doi.org/10.1016/j.jep....   https://doi.org/10.1002/ffj.32...

Pharmacokinetics — Magnolia champaca

Data on the pharmacokinetics of Magnolia champaca in clinical settings are limited, however, based on studies of plant extracts and essential oils containing similar classes of compounds, general patterns can be identified. Upon oral administration, extracts and powders undergo primary processing in the gastrointestinal tract with partial absorption of phenolic compounds and terpenes in the small intestine. Biotransformation begins already at the stage of the intestinal mucosa and continues in the liver with the participation of microsomal oxidation enzymes. Part of the flavonoids and other polyphenols is metabolized by the intestinal microflora, forming simpler phenolic acids, which are more easily absorbed.

With transdermal administration in the form of essential oils and infusions, active components penetrate the stratum corneum of the epidermis and reach the dermis, where they partially bind to the lipid structures of the skin. Systemic absorption through the skin is limited, but for volatile components, entry into the bloodstream and lymph is possible. With the inhalation route, essential fractions are absorbed through the alveolar membrane, quickly entering the systemic circulation and reaching the central nervous system.

The distribution of active substances is characterized by predominant accumulation of lipophilic components in adipose tissue, skin, and mucous membranes. Metabolism occurs in the liver with the formation of conjugates with glucuronic and sulfuric acids. Water-soluble metabolites are excreted by the kidneys in urine, while more lipophilic ones are excreted with bile and partially through the skin with sweat. Volatile components are partially eliminated through the lungs with exhaled air.

This pharmacokinetic model suggests a significant influence of the route of administration and the composition of the pharmacological form on the rate and extent of absorption, distribution, and elimination, which must be taken into account when developing regimens for the use of Magnolia champaca in medical and cosmetic practice.

References: https://doi.org/10.1016/j.jep....   https://doi.org/10.1002/ffj.32...

Mechanisms of Action and Scientific Rationale — Magnolia champaca

The pharmacological activity of Magnolia champaca is determined by a complex of secondary metabolites, including mono- and sesquiterpenoids (linalool, α-pinene, β-caryophyllene), phenolic compounds (flavonoids, phenolic acids), alkaloids, and other phytochemical components. Monoterpenes and phenolic compounds are capable of modulating the activity of enzyme systems such as cyclooxygenase (COX) and lipoxygenase (LOX), reducing the biosynthesis of pro-inflammatory mediators — prostaglandins and leukotrienes. Flavonoids and phenolic acids exhibit antioxidant properties due to electron donation and stabilization of free radicals, as well as modulation of NF-κB and MAPK signaling cascades, which leads to a decrease in the expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α).

Some components of Magnolia champaca essential oil interact with neurotransmitter systems, including GABAergic and serotonergic, which is confirmed by their affinity for the corresponding receptors identified in vitro. These interactions are accompanied by modulation of ion channel activity and voltage-dependent calcium fluxes, which affects neuronal excitability and the state of the central nervous system. Sesquiterpenes, such as β-caryophyllene, can act as an agonist of cannabinoid receptors CB2, mediating anti-inflammatory effects through immunocompetent cells, including macrophages and neutrophils.

At the cellular level, Magnolia champaca extracts demonstrate the ability to suppress oxidative damage to membrane lipids, protecting endothelial cells and skin cells from peroxide stress. The mechanisms of antibacterial action are associated with disruption of the permeability of microbial cell walls and inhibition of enzymes involved in cell wall synthesis. Antifungal activity is realized through disruption of membrane integrity and inhibition of mitochondrial functions of fungal cells. There is also evidence of the ability of individual components to affect dopaminergic receptors and acetylcholinesterase (AChE), indicating a potential effect on cognitive processes and neuroprotection.

References: https://doi.org/10.1016/j.jep....    https://doi.org/10.1002/ffj.32...

Synergy — Magnolia champaca

Studies demonstrate that Magnolia champaca exhibits pharmacological synergy when combined with a number of other plant taxa and biologically active substances. Combined use with Curcuma longa (turmeric) enhances antioxidant activity due to the additive effect of polyphenols and curcuminoids aimed at inhibiting the NF-κB cascade and suppressing the production of pro-inflammatory cytokines. The combination with Ocimum sanctum (holy basil) revealed a potentiating antimicrobial effect against gram-positive bacteria, due to synergistic disruption of membrane integrity and blockade of bacterial enzyme systems.

When combined with Withania somnifera (ashwagandha), a modulating effect on the hypothalamic-pituitary-adrenal axis is observed, which is associated with the interaction of triterpenoids and alkaloids of both plants with glucocorticoid receptors. Magnolia champaca in combination with Centella asiatica (gotu kola) exhibits an additive regenerative effect on the skin, which is explained by the simultaneous stimulation of fibroblasts and increased collagen synthesis under the influence of triterpene saponins and phenolic compounds.

Synergy with Piper nigrum (black pepper) is due to the presence of piperine, which can increase the bioavailability of lipophilic components of Magnolia champaca by inhibiting first-phase metabolism enzymes, thereby enhancing the systemic action of terpenoids and flavonoids. When combined with Melaleuca alternifolia (tea tree) in external compositions, potentiation of antifungal activity has been noted, associated with simultaneous damage to fungal cell membranes and disruption of energy metabolism.

References: https://doi.org/10.1016/j.jep....  https://doi.org/10.1002/ffj.32...  https://doi.org/10.1016/j.phym...

Geography of Use and Traditional Medicine — Magnolia champaca

Magnolia champaca is traditionally used in the countries of South and Southeast Asia, including India, Nepal, Sri Lanka, Myanmar, Thailand, Laos, Cambodia, Vietnam, Malaysia, and Indonesia. In the Indian Ayurvedic tradition, the plant is used in the form of decoctions and infusions of flowers, bark, and leaves, as well as in the form of aromatic oils used for body and hair care. In Tibetan medicine, Magnolia champaca petals were part of complex mixtures used to balance vital energies. In Thailand and Laos, the flowers are used in the form of steam inhalations and oil macerates, including for cosmetic purposes.

Ethnographic records document the use of Magnolia champaca in ritual and cultural practice: flowers are traditionally offered in Hindu and Buddhist temples, woven into garlands and body adornments. Among the peoples of South India, flowers were considered a symbol of purity and spiritual elevation, used in wedding ceremonies and initiation rites. In some regions of Indonesia and Malaysia, Magnolia champaca essential oil was used in purification rituals and as a protective fragrance against evil spirits.

Historical references to the use of Magnolia champaca are found in ancient Indian texts, including the Charaka Samhita and Sushruta Samhita, where the plant was described as a valuable aromatic and medicinal agent. In ceramic finds in South India (dating from the 1st millennium AD), residues of vegetable oils presumably containing components of Magnolia champaca were discovered. Chinese sources from the Tang Dynasty record mention of imported aromatic flowers similar in description to champak.

In a non-medical context, Magnolia champaca served as a perfumery plant, used for scenting clothes, storing fabrics, and also as incense. In some villages in Myanmar and Nepal, flowers were burned in evening rituals as a means to pacify the spirit and attract well-being to the home.